News search

    E.g., 22/11/2024
    E.g., 22/11/2024
    Miguel Galán, David Sancho, Stefanie K. Wculek, Annalaura Mastrangelo, Verónica Miguel ,Ignacio Heras-Murillo, Diego Mañanes, José Antonio Enríquez and Andrea Curtabbi.
    Research
    3 Feb 2023
    IMMUNITY: Scientists identify a new therapeutic target in macrophages for the treatment of obesity-related diseases

    The discovery, published in the journal Immunity, identifies a new therapeutic route for conditions associated with obesity and metabolic syndrome, including cardiovascular disease
    Research
    17 Sep 2020
    Nature Metabolism: CNIC researchers discover a mechanism allowing immune cells to regulate obesity

    The results published in Nature Metabolism could be useful to design new treatments for the obese and overweight, and for some associated pathologies, including fatty liver disease and type 2 diabetes
    Microscopía confocal mostrando un macrófago peritoneal de un ratón deficiente en RXR, donde se observa un alto contenido de lípidos (verde) dentro de vesículas ácidas (rojo).
    Research
    3 Apr 2020
    Nature Communications: CNIC scientists discover a new molecular mechanism that regulates the sentinel cells of the immune system

    Published in Nature Communications, the study suggests that it may be possible to regulate the number and activity of these macrophages with drugs that modulate the nuclear receptor RXR
    Noelia Alonso-González, Juan Antonio Quintana y Andrés Hidalgo.
    Research
    24 Apr 2017
    'Journal of Experimental Medicine': Cell “canibalism” educates our defenses

    CNIC scientists show that when macrophages ingest these expired cells they acquire protective properties
    Research
    5 Jun 2012
    Tamas Röszer galardonado por el Programa de Becas para Jóvenes Investigadores de Lilly y la EFSD

     El Dr. Röszer ha sido premiado por su investigación: "Dianas específicas de receptores x retinoides en macrófagos: papel en la diabetes tipo 2